The Latin America, Middle East and Africa Neurocognitive Assessment And Rehabilitation Market would witness market growth of 10.5% CAGR during the forecast period (2023-2030).
Ongoing advancements in neuroscience and the continuous exploration of neuroplasticity drive the development of innovative assessment tools and rehabilitation techniques. The state of healthcare infrastructure, including the availability of specialized facilities and skilled professionals, significantly influences the accessibility and quality of services. Disparities in healthcare infrastructure can impact the reach of these services, particularly in underserved regions.
The regulatory landscape is crucial in shaping the market. Stricter regulations ensure the safety and efficacy of assessment tools and rehabilitation interventions, fostering trust among healthcare professionals and patients. Public awareness regarding the importance of cognitive health and the availability of assessment and rehabilitation services is instrumental in fostering early intervention. Additionally, reducing the stigma associated with cognitive disorders encourages individuals to seek timely assessments and engage in rehabilitation programs.
The National Library of Medicine estimates that the prevalence of Alzheimer's disease in Saudi Arabia is 5% overall, with a progressive increase in prevalence after age 65. The prevalence of dementia in the Middle East is estimated to be 10% for people aged 75-79, 16% among individuals aged 80-84, and 29% among those aged 85 and older. There is a growing recognition of the importance of early detection and intervention in dementia. Neurocognitive assessments play a crucial role in identifying cognitive changes at an early stage, allowing for timely diagnosis and the initiation of appropriate rehabilitation strategies. Thus, the above aspects will expand the market growth across the region in the upcoming years.
The Brazil market dominated the LAMEA Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $567.1 Million by 2030. The Argentina market is showcasing a CAGR of 11.1% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.2% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
Ongoing advancements in neuroscience and the continuous exploration of neuroplasticity drive the development of innovative assessment tools and rehabilitation techniques. The state of healthcare infrastructure, including the availability of specialized facilities and skilled professionals, significantly influences the accessibility and quality of services. Disparities in healthcare infrastructure can impact the reach of these services, particularly in underserved regions.
The regulatory landscape is crucial in shaping the market. Stricter regulations ensure the safety and efficacy of assessment tools and rehabilitation interventions, fostering trust among healthcare professionals and patients. Public awareness regarding the importance of cognitive health and the availability of assessment and rehabilitation services is instrumental in fostering early intervention. Additionally, reducing the stigma associated with cognitive disorders encourages individuals to seek timely assessments and engage in rehabilitation programs.
The National Library of Medicine estimates that the prevalence of Alzheimer's disease in Saudi Arabia is 5% overall, with a progressive increase in prevalence after age 65. The prevalence of dementia in the Middle East is estimated to be 10% for people aged 75-79, 16% among individuals aged 80-84, and 29% among those aged 85 and older. There is a growing recognition of the importance of early detection and intervention in dementia. Neurocognitive assessments play a crucial role in identifying cognitive changes at an early stage, allowing for timely diagnosis and the initiation of appropriate rehabilitation strategies. Thus, the above aspects will expand the market growth across the region in the upcoming years.
The Brazil market dominated the LAMEA Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $567.1 Million by 2030. The Argentina market is showcasing a CAGR of 11.1% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.2% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
Scope of the Study
Market Segments Covered in the Report:
By Component- Neurorehabilitation Therapy
- Neurocognitive Assessment Testing
- Rehab Centers
- Hospital & Clinics
- Homecare Settings
- Physiotherapy Centers
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Neurocognitive Assessment And Rehabilitation Market by Component
Chapter 5. LAMEA Neurocognitive Assessment And Rehabilitation Market by Providers
Chapter 6. LAMEA Neurocognitive Assessment And Rehabilitation Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Methodology
LOADING...
